A single-center observational study of nirsevimab for prevention of RSV infection in preterm infants - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

An Observational Study on the Use of Nirsevimab for RSV Infection Prevention in Preterm Infants at a Single Center

  • By

  • Rina Su

  • Rigonggaowa A

  • Fang Yao

  • Yanbin An

  • Cheng Cai

  • Lei Yun

  • July 8, 2026

Share

Original Source(s)

A single-center observational study of nirsevimab for prevention of RSV infection in preterm infants

  • by Rina Su, Rigonggaowa A, Fang Yao, Yanbin An, Cheng Cai, Lei Yun

  • July 8, 2026

Related Content

Completion Rates of Screening Examinations for Hearing Among Preschool-Aged Children

FDA approves first therapy for warm autoimmune hemolytic anemia

The phase 2/3 ENERGY trial evaluated durable hemoglobin response with nipocalimab vs placebo in adults with warm autoimmune hemolytic anemia.

A pretreatment multiphasic CT-based decision-support model for differentiating pediatric hepatoblastoma from focal nodular hyperplasia